Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function (BETAMI)

NCT03646357 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT03646357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03646357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function (BETAMI)
Lead sponsor
Oslo University Hospital
Phase
Phase 4
Overall status
Active, not recruiting
Start date
October 1, 2018
Completion date
December 10, 2035
Enrollment
2,895 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction, non-st elevation myocardial infarction, st elevation myocardial infarction